Clinical and Economic Outcomes of Staphylococcus aureusSepticemia in ESRD Patients Receiving Hemodialysis

MLA

Nissenson, Allen R., et al. “Clinical and Economic Outcomes of Staphylococcus AureusSepticemia in ESRD Patients Receiving Hemodialysis.” American Journal of Kidney Diseases, vol. 46, no. 2, Aug. 2005, pp. 301–08. EBSCOhost, https://doi.org/10.1053/j.ajkd.2005.04.019.

APA

Nissenson, A. R., Dylan, M. L., Griffiths, R. I., Yu, H.-T., Dean, B. B., Danese, M. D., & Dubois, R. W. (2005). Clinical and Economic Outcomes of Staphylococcus aureusSepticemia in ESRD Patients Receiving Hemodialysis. American Journal of Kidney Diseases, 46(2), 301–308. https://doi.org/10.1053/j.ajkd.2005.04.019

Chicago

Nissenson, Allen R., Michelle L. Dylan, Robert I. Griffiths, Hsing-Ting Yu, Bonnie B. Dean, Mark D. Danese, and Robert W. Dubois. 2005. “Clinical and Economic Outcomes of Staphylococcus AureusSepticemia in ESRD Patients Receiving Hemodialysis.” American Journal of Kidney Diseases 46 (2): 301–8. doi:10.1053/j.ajkd.2005.04.019.